Evidence map›Paper›PMID 40018107›Full record

ArticleBMJ public health2024

Incidence and contributing factors of dementia among people living with HIV in British Columbia, Canada, from 2002 to 2016: a retrospective cohort study.

Sara Shayegi-Nik, William G Honer, Fidel Vila-Rodriguez, Ni Gusti Ayu Nanditha, Thomas L Patterson, Silvia Guillemi, Hasan Nathani, Jason Trigg, Weijia Yin, Alejandra Fonseca and 4 more

Abstract read
In one paragraph

Article in BMJ public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Time-to-event analysis.Perspectives in clinical research
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sara Shayegi-NikBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.ORCID 0009-0004-3163-4118
William G HonerDepartment of Psychiatry, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
Fidel Vila-RodriguezDepartment of Psychiatry, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
Ni Gusti Ayu NandithaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Thomas L PattersonDepartment of Psychiatry, University of California San Diego, La Jolla, California, USA.
Silvia GuillemiBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Hasan NathaniBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Jason TriggBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Weijia YinBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Alejandra FonsecaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Bronhilda T TakehBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Rolando BarriosBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Julio S G MontanerBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Viviane D LimaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Dementia is a progressive and debilitating disease, and people living with HIV (PLWH) often develop dementia much earlier than those not living with HIV. We estimated the incidence and prevalence of dementia and identified its key risk factors in a cohort of PLWH in British Columbia, Canada. Methods: This retrospective cohort study used data from the Seek and Treat for Optimal Prevention of HIV/AIDS study. Eligible individuals were diagnosed with HIV, ≥40 years of age, naïve to antiretroviral therapy (ART), had no dementia at the index date and were followed for ≥1 year during 2002-2016. Our main outcome was incident dementia. We examined the effect of sociodemographic and clinical covariates on the incidence of dementia using a cause-specific hazard (CSH) model, with all-cause mortality as a competing risk event. Results: Among 5121 eligible PLWH, 108 (2%) developed dementia. The crude 15-year prevalence of dementia was 2.1%, and the age-sex standardised incidence rate of dementia was 4.3 (95% CI: 4.2 to 4.4) per 1000 person-years. Among the adjusted covariates, CD4 cell count<50 cells/mm Conclusions: We demonstrated the negative role of immunosuppression and inflammation on the incidence of dementia among PLWH. Our study also calls for the enhanced integration of care services provided for HIV, mental health, SUD and other risk-inducing comorbidities as a means of lowering the risk of dementia within this population.

Indexed as

EpidemiologyHIVPublic Health

Identifiers

PMID40018107
PMCPMC11816979

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.